JP2016029071A5 - - Google Patents

Download PDF

Info

Publication number
JP2016029071A5
JP2016029071A5 JP2015191288A JP2015191288A JP2016029071A5 JP 2016029071 A5 JP2016029071 A5 JP 2016029071A5 JP 2015191288 A JP2015191288 A JP 2015191288A JP 2015191288 A JP2015191288 A JP 2015191288A JP 2016029071 A5 JP2016029071 A5 JP 2016029071A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
composition according
pharmaceutical composition
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015191288A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016029071A (ja
JP6183757B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2015191288A priority Critical patent/JP6183757B2/ja
Priority claimed from JP2015191288A external-priority patent/JP6183757B2/ja
Publication of JP2016029071A publication Critical patent/JP2016029071A/ja
Publication of JP2016029071A5 publication Critical patent/JP2016029071A5/ja
Application granted granted Critical
Publication of JP6183757B2 publication Critical patent/JP6183757B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015191288A 2012-11-28 2015-09-29 細胞膜透過性の線維芽細胞増殖因子の医療用途 Expired - Fee Related JP6183757B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015191288A JP6183757B2 (ja) 2012-11-28 2015-09-29 細胞膜透過性の線維芽細胞増殖因子の医療用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012259816 2012-11-28
JP2012259816 2012-11-28
JP2015191288A JP6183757B2 (ja) 2012-11-28 2015-09-29 細胞膜透過性の線維芽細胞増殖因子の医療用途

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014510567A Division JP5818977B2 (ja) 2012-11-28 2013-11-11 細胞膜透過性の線維芽細胞増殖因子の医療用途

Publications (3)

Publication Number Publication Date
JP2016029071A JP2016029071A (ja) 2016-03-03
JP2016029071A5 true JP2016029071A5 (https=) 2016-05-26
JP6183757B2 JP6183757B2 (ja) 2017-08-23

Family

ID=50827673

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014510567A Expired - Fee Related JP5818977B2 (ja) 2012-11-28 2013-11-11 細胞膜透過性の線維芽細胞増殖因子の医療用途
JP2015191288A Expired - Fee Related JP6183757B2 (ja) 2012-11-28 2015-09-29 細胞膜透過性の線維芽細胞増殖因子の医療用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014510567A Expired - Fee Related JP5818977B2 (ja) 2012-11-28 2013-11-11 細胞膜透過性の線維芽細胞増殖因子の医療用途

Country Status (3)

Country Link
US (1) US20150299280A1 (https=)
JP (2) JP5818977B2 (https=)
WO (1) WO2014084027A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6675150B2 (ja) * 2015-04-06 2020-04-01 公立大学法人大阪 サイトグロビン発現増強剤
US10385113B2 (en) 2016-03-30 2019-08-20 The Board Of Trustees Of The University Of Arkansas Engineered FGF compositions and methods of use thereof
US11267855B2 (en) 2018-03-16 2022-03-08 The Board Of Trustees Of The University Of Arkansas Engineered FGF1 and FGF2 compositions and methods of use thereof
CN114829582A (zh) * 2019-12-16 2022-07-29 Jsr株式会社 类器官的制造方法
CN114874990A (zh) * 2021-02-05 2022-08-09 中国科学院苏州纳米技术与纳米仿生研究所 一种功能化外泌体及其制备方法和应用
CZ309550B6 (cs) * 2021-06-15 2023-04-05 Enantis s.r.o Termostabilní polypeptid na bázi FGF18 a jeho použití

Similar Documents

Publication Publication Date Title
JP2016029071A5 (https=)
JPWO2019156137A5 (https=)
JP2019194251A5 (https=)
FI3352776T3 (fi) Htt-repressoreita ja niiden käyttötapoja
AR065289A1 (es) Antagonistas de activina - actriia y sus usos para la promocion del crecimiento oseo y el tratamiento de mieloma multiple
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
HRP20231496T1 (hr) Cistein proteaza
WO2010135491A3 (en) Fibroblast growth factor mutants having improved functional half-life and methods of their use
EP2189471A4 (en) FOXM1 PEPTIDE AND MEDICAMENT THEREFOR
BR112021015751A2 (pt) Vetores de terapia genética para tratamento da doença de danon
JP2017006120A5 (https=)
PH12019502522A1 (en) Oncolytic virus and method
JP2017532343A5 (https=)
JP2017524380A5 (ja) 腫瘍血管遮断剤であるポリペプチド、遺伝子、発現ベクター、腫瘍血管遮断剤の組成物、及び腫瘍血管遮断剤であるポリペプチドの調製方法
RU2017116973A (ru) Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса
AR068020A1 (es) Terapia combinada para el cancer de pancreas usando un peptido antigenico y un agente quimioterapeutico
MX2017006372A (es) Composiciones y metodos para prevenir o tratar enfermedades, condiciones o procesos caracterizados por proliferacion de fibroblasto aberrante y matrix extracelular.
MX385860B (es) Peptido para usarse para reducir la necesidad de cirugía en pacientes que tienen hiperplasia prostática beningna.
IL312730A (en) Antimicrobial peptides and methods of using same
JP6183757B2 (ja) 細胞膜透過性の線維芽細胞増殖因子の医療用途
AR095076A1 (es) Péptidos y composiciones para el tratamiento de daño articular
JP2017513856A5 (https=)
TWI496579B (zh) 類鋅手指胜肽、其表現質體、及包含其之醫藥組成物之用途
MX2022004799A (es) Composiciones y metodos para el tratamiento de los trastornos de almacenamiento de glucogeno.
BR112018071215A2 (pt) peptídeo para uso no tratamento, melhora ou prevenção de osteoartrite